Viewing the Development of the Antihypertensive Drugs in China through Comparison among 6 Editions of New Materia Medica
- VernacularTitle:比对6个版次的《新编药物学》看我国临床降压药物发展
- Author:
Shuguang GONG
- Publication Type:Journal Article
- Keywords:
New Materia Medica;
Antihypertensive drug;
Development
- From:
China Pharmacy
2007;0(31):-
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE: To discuss the development of the antihypertensive drugs in China. METHODS: The varieties of antihypertensive drugs in New Materia Medica from the 11th (1981) to 16th edition (2007) were analyzed statistically. RESULTS & CONCLUSIONS: The antihypertensive drugs in China has experienced a great development ever since 1997 (14th edition) in that the varieties of adrenoreceptor blockers, calcium-channel blocker, angiotensin-converting enzyme inhibitors and Ang Ⅱ receptor blockers had been increased, thus safer and more effective drugs were available for hypertensive patients meanwhile the case fatality was able to be reduced.
